Survey and Reports

Q1 2023 Cappitech Newsletter

Gain valuable insights from Cappitech’s Q1 2023 newsletter. Explore the latest topics affecting reg reporting such the EMIR REFIT and the challenges it poses, as well as the new UPI and the importance it holds for firms reporting OTC products. Read also the latest regime updates from EMEA, APAC and NoA. We also include a new section covering Cappitech & the Community as well as updates from our managed services and customer success teams.

Download here.


Download the Report Now